Menneskeheden risikerer at tabe kapløbet med stadig mere modstandsdygtige (multiresistente) bakterier, efterhånden som “mirakelvåbnet” – antibiotika – mister sin virkning og det kan især ramme u-landenes befolkninger.
LONDON, 29 June 2012 (IRIN): Almost one in every five deaths worldwide occurs as a result of infection, but many bacterial illnesses will become incurable as the efficacy (virkning) of current antibiotic drugs wanes (daler), according to the World Health Organization (WHO).
“The world is on the brink of losing these miracle cures,” WHO announced in 2011. It sounded like the farewell to a generation of familiar, dependable antibiotics after more than half a century of service.
In some countries that brink has already been crossed, said Laura Piddock.
She is director of the UK-based initiative, Antibiotic Action, and founder of the Antimicrobial Agents Research Group at the UK’s Birmingham University.
For too long people have taken for granted that there will be antibiotics to kill the bacteria, but the bacteria have been mutating (undergået forandringer) to develop defences against those very same antibiotics.
Streptococcus pneumoniae (bakterie af streptokok-slægten, der fører til lungebetændelse). is a major cause of pneumonia, among many other serious infections.
Escherichia coli, or E. coli (sygdomsfremkaldende koli-bakterie), is a leading cause of diarrhoeal (diarre) diseases.
Staphylococcus aureus or S. aureus (gule stafylokokker) is responsible for many ailments, from minor skin infections to pneumonia, meningitis (hjernehindebetændelse), toxic shock syndrome and sepsis (sårbetændelse/blodforgiftning).
“Whereas resistance has been addressed for the past four decades by experts in the industrialized world, studies describing the problem and the public health situation in the developing world have lagged behind,” noted a recent book by the Alliance for the Prudent Use of Antibiotics, at the US-based Tufts University.
As drugs take longer to cure illnesses or are no longer effective, even minor infections can become deadly, wrote a representative from the global pharmaceutical company, GlaxoSmithKline (GSK).
Causes
Læs videre på
http://www.irinnews.org/Report/95768/HEALTH-The-hunt-for-new-antibiotics